Actively Recruiting
A Non-interventional, Prospective Study With Benralizumab
Led by AstraZeneca · Updated on 2026-04-13
300
Participants Needed
41
Research Sites
157 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective, non-interventional, single-arm, multicenter study to investigate asthma control, and health-related quality of life (HRQL), lung function and asthma medication intake in severe eosinophilic asthma patients treated with benralizumab in a real-life setting in Germany.
CONDITIONS
Official Title
A Non-interventional, Prospective Study With Benralizumab
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female patients aged 18 years or older
- Confirmed diagnosis of severe eosinophilic asthma treated with high-dose inhaled corticosteroids plus long-acting beta agonists
- Prescribed benralizumab according to label and local reimbursement criteria
- Benralizumab treatment decision made prior and independently of the study
- Ability and willingness to read and understand written instructions
- Signed informed consent form indicating understanding and willingness to participate
- Willingness to report asthma patient-reported outcomes every 4 weeks and medication intake weekly
You will not qualify if you...
- Participation in another observational trial that might influence this study or randomized clinical trial within the last 3 months
- History of anaphylaxis to any biologic therapy
- Prior treatment with any asthma biologic therapy within the last 6 months
- Concurrent asthma biologic therapy
- Untreated or unresponsive helminth parasitic infection diagnosed within 24 weeks prior to consent
- Any other pulmonary disease that may affect study results
- Any acute or chronic condition limiting questionnaire completion or study participation
- Current or history of malignancy within 5 years except for treated in-situ cervical carcinoma in remission at least 12 months and basal cell or superficial squamous skin cancer
- Pregnancy or lactation
- Any condition that may jeopardize patient safety as per investigator's opinion
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 41 locations
1
Research Site
Ahrensburg, Germany
Actively Recruiting
2
Research Site
Ansbach, Germany
Actively Recruiting
3
Research Site
Aschaffenburg, Germany
Actively Recruiting
4
Research Site
Auerbach, Germany
Actively Recruiting
5
Research Site
Augsburg, Germany
Actively Recruiting
6
Research Site
Bad Homburg, Germany
Actively Recruiting
7
Research Site
Berlin, Germany
Actively Recruiting
8
Research Site
Cottbus, Germany
Actively Recruiting
9
Research Site
Darmstadt, Germany
Actively Recruiting
10
Research Site
Dresden, Germany
Actively Recruiting
11
Research Site
Düsseldorf, Germany
Actively Recruiting
12
Research Site
Ehringshausen, Germany
Actively Recruiting
13
Research Site
Erkelenz, Germany
Actively Recruiting
14
Research Site
Essen, Germany
Actively Recruiting
15
Research Site
Flensburg, Germany
Actively Recruiting
16
Research Site
Frankfurt am Main, Germany
Actively Recruiting
17
Research Site
Garmisch-Partenkirchen, Germany
Actively Recruiting
18
Research Site
Halle, Germany
Actively Recruiting
19
Research Site
Hamburg, Germany
Actively Recruiting
20
Research Site
Hanover, Germany
Actively Recruiting
21
Research Site
Heidelberg, Germany
Withdrawn
22
Research Site
Heidelberg, Germany
Actively Recruiting
23
Research Site
Hohenstein-Ernsttahl, Germany
Actively Recruiting
24
Research Site
Itzehoe, Germany
Actively Recruiting
25
Research Site
Jena, Germany
Actively Recruiting
26
Research Site
Leipzig, Germany
Actively Recruiting
27
Research Site
Loerrach, Germany
Actively Recruiting
28
Research Site
Lübeck, Germany
Actively Recruiting
29
Research Site
Lüneburg, Germany
Actively Recruiting
30
Research Site
Markkleeberg, Germany
Actively Recruiting
31
Research Site
Mönchengladbach, Germany
Actively Recruiting
32
Research Site
Neuruppin, Germany
Actively Recruiting
33
Research Site
Nuremberg, Germany
Actively Recruiting
34
Research Site
Papenburg, Germany
Actively Recruiting
35
Research Site
Rostock, Germany
Actively Recruiting
36
Research Site
Saalfeld, Germany
Actively Recruiting
37
Research Site
Spardorf, Germany
Actively Recruiting
38
Research Site
Weißenburg, Germany
Actively Recruiting
39
Research Site
Wilhelmshaven, Germany
Actively Recruiting
40
Research Site
Würzburg, Germany
Actively Recruiting
41
Research Site
Zossen, Germany
Actively Recruiting
Research Team
A
AstraZeneca Clinical Study Information Center
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here